- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02516917
The Feasibility of a Brief Attention Training Technique in Improving Behaviour and Attention in Children With ADHD
The Feasibility of a Brief Attention Training Technique for Improving Behaviour and Attention in Children With ADHD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Attention deficit hyperactivity disorder (ADHD) is a neurobehavioural disorder characterised by core symptoms of hyperactivity, impulsivity and inattention. Its prevalence ranges between 3-9% of school-aged children, making it one of the most common presentations in child and adolescent mental health services.
In the last 10 years, research into the effectiveness of attention training as an intervention for children with ADHD has been increasing. This has tended to follow assumptions that children with the disorder either lack skills in focusing and maintaining their attention and/or have neurological deficits in areas responsible for attention functions. Results have been encouraging, with study participants demonstrating improvements in symptoms and behaviour following a course of attention training. However, the method and length of training has varied across studies.
This study aims to investigate a treatment called the Attention Training Technique (ATT) that approaches attention difficulties in this disorder from a different perspective. Instead of viewing inattention as a result of structural or skills deficits, it posits that children with ADHD have these skills, but are perhaps unaware of the flexibility and control they have over them. This treatment aims to increase this awareness and subsequently improve ratings of attention, behaviour and other areas of executive functioning.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Manchester, United Kingdom, M13 9PL
- University of Manchester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children with a formal diagnosis of ADHD as given by a psychiatrist or community paediatrician
- Children between the ages of 7 and 11. This age group was selected as previous research on attention training in this population has used this age group
- Children who are currently on a waiting list at a Child and Adolescent Mental Health Service (CAMHS) or a child psychology service, or being seen by a CAMHS or psychology service for medication review only
- Children who speak fluent English which will ensure they are able to comprehend the tasks instructions adequately.
Exclusion Criteria:
- Children who are not stabilised on stimulant medication and/or willing to maintain their medication type/dose
- Children with a major neurological illness or acquired central nervous system injury
- Children who at the point of referral have a co-existing diagnosis of an Autistic Spectrum Disorder
- Children who are currently in receipt of another non-pharmacological intervention for ADHD or who are currently taking part in another research trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Attention Training Technique (ATT)
Participants will receive 3-5 sessions of the ATT over a period of 3-5 weeks.
A set of standardised instructions will be read to each participant and then they will engage in the procedure for a period of 12 minutes.
Participants will listen to a set of auditory stimuli and follow the directions of the recording.
This will ask them to focus their attention on selected sounds or spatial locations, switch attention between different sounds and locations, before allocating their attention to all sounds simultaneously.
Participants will be given a recording of the ATT on a C.D and asked to practice this at least once before the second session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inattention on the Swanson, Nolan and Pelham questionnaire (Snap-IV)
Time Frame: Change from baseline in attention post treatment and at follow up 6 weeks later
|
Parent's rating of their child's inattentiveness
|
Change from baseline in attention post treatment and at follow up 6 weeks later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hyperactivity on the Swanson, Nolan and Pelham questionnaire (Snap-IV)
Time Frame: Change from baseline in hyperactivity post treatment and at follow up 6 weeks later
|
Parent's rating of their child's hyperactivity
|
Change from baseline in hyperactivity post treatment and at follow up 6 weeks later
|
|
Impulsivity on the Swanson, Nolan and Pelham questionnaire (Snap-IV)
Time Frame: Change from baseline in impulsivity post treatment and at follow up 6 weeks later
|
Parent's rating of their child's impulsivity
|
Change from baseline in impulsivity post treatment and at follow up 6 weeks later
|
|
Attentional control on the Attentional Control Scale for Children (ASC-C)
Time Frame: Change from baseline in attentional control post treatment and at follow up 6 weeks later
|
Children's self reported ability to focus and shift their attention
|
Change from baseline in attentional control post treatment and at follow up 6 weeks later
|
|
Behaviour on the Strengths and Difficulties Questionnaire (SDQ)
Time Frame: Change from baseline in behaviour post treatment and at follow up 6 weeks later
|
Parent's ratings of their child's behaviours
|
Change from baseline in behaviour post treatment and at follow up 6 weeks later
|
|
Executive functioning on The Behavioural Rating Inventory of Executive Functioning (BRIEF)
Time Frame: Change from baseline in executive functioning post treatment and at follow up 6 weeks later
|
Parent's ratings of their child's executive functioning behaviours in the home environment
|
Change from baseline in executive functioning post treatment and at follow up 6 weeks later
|
|
Working memory on the Weschler Intelligence Scale for Children (WISC-IV) - Digit Span
Time Frame: Change from baseline in working memory post treatment and at follow up 6 weeks later
|
Children's Working memory as assessed by the Digit Span subtest
|
Change from baseline in working memory post treatment and at follow up 6 weeks later
|
|
Working memory on the Weschler Intelligence Scale for Children (WISC-IV) - Letter Number Sequencing
Time Frame: Change from baseline in working memory post treatment and at follow up 6 weeks later
|
Children's Working memory as assessed by the Letter Number Sequencing subtest
|
Change from baseline in working memory post treatment and at follow up 6 weeks later
|
|
Treatment Acceptability Questionnaire
Time Frame: Rated once at the final session of treatment, 4 weeks after the 2nd baseline is taken
|
Parents rating of the acceptability of the treatment
|
Rated once at the final session of treatment, 4 weeks after the 2nd baseline is taken
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Adrian Wells, University of Manchester
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 163562
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Louisiana State University Health...Recruiting
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Attention Training Technique
-
Vestre Viken Hospital TrustUniversity of Oslo; Oslo University Hospital; The Hospital of VestfoldRecruitingCoronary Artery Disease | Depression, AnxietyNorway
-
University of ManchesterNorthern Care Alliance NHS Foundation Trust; Manchester University NHS Foundation...Not yet recruitingStroke | Crying | Pseudobulbar Affect | Emotionality | Lability EmotionalUnited Kingdom
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioCompletedExcessive WorryCanada
-
University of LiegeUnknown
-
Northern Illinois UniversityCompleted
-
Norwegian University of Science and TechnologyCompletedDepression | Stress, Psychological | AnxietyNorway
-
Technical University of MunichGerman Research Foundation; Studienstiftung des deutschen VolkesCompletedExperimental Pain in Healthy Human SubjectsGermany
-
Mclean HospitalTerminatedDepression | Attention Training | Symptoms, Cognitive | Symptoms, Affective | Symptoms, BehavioralUnited States
-
University of California, San FranciscoCompleted